[Approach to the treatment of intractable nephrotic syndrome].
D003520:Cyclophosphamide / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000401:mortality; D011239:Prednisolone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D004176:Dipyridamole; D003520:Cyclophosphamide; D011239:Prednisolone; D007213:Indomethacin